Professeur Mart Saarma, de l’Université de Helsinki, donne une conférence le 4 Mars 2015 à 14h à l’ENS de Lyon, intitulée « Novel Neurotrophic Factors for Parkinson’s Disease ».
Prof Saarma est également le vice-président du European Research Council (ERC)
14:00 VENDREDI 6 MARS, 2015
ENS LYON – Site Monod* – Salle des Thèses Chantal Rabourdin-Combe
Novel Neurotrophic Factors for Parkinson’s Disease
Prof. Mart SAARMA
Director of the Centre of Excellence in Molecular and Integrated Neuroscience Research Institute of Biotechnology, University of Helsinki, Finland
Mart Saarma is the Professor of Biotechnology and Director of the Laboratory of Molecular Neuroscience at the Institute of Biotechnology, University of Helsinki, Finland. He has studied the structure, biology and therapeutic potential neurotrophic factors and their receptors. His recent studies are focused on the role of neurotrophic factors in development and neurodegenerative diseases. His group has characterized several new GDNF family receptors and demonstrated that RET receptor tyrosine kinase is the signalling receptor for GDNF. Recently his group has discovered a new neurotrophic factor CDNF and shown that it very efficiently protects and repairs dopamine neurons in animal models of Parkinson’s disease. He has received several domestic and international science prizes, including the Nordic Science Prize by Lundbeck Foundation in 2009. He is the member of several academies and EMBO. Currently he is the member of EMBO Council and Vice President of the European Research Council (ERC).
Organisateurs : ENS de Lyon
Partenaires: ARC2, ERC, UCBL, Université de Lyon, SFR Biosciences, Hôpitaux de Lyon